Why the study?
The study aimed to systematize available data on the epidemiology and diagnosis of metabolic syndrome in polycystic ovary syndrome.
Answers are grounded in this paper and cite their sources.
Women with PCOS, particularly those with hyperandrogenic phenotypes, have a high prevalence of metabolic syndrome and increased cardiovascular risk.
The purpose of the review was to systematize the available data on the epidemiology and diagnosis of the metabolic syndrome (MetS) in polycystic ovary syndrome (PCOS). The information search was conducted using Internet resources (PubMed, EMBASE, Google Scholar, E-Library) and literature sources for the years 2000-2020. The modern studies indicate that the prevalence of metabolic disorders varies in groups of women with different PCOS phenotypes. Numerous risk factors in PCOS lead to a significant increase in risk for cardiovascular diseases. Patients with PCOS diagnosed according to AE-PCOS Society criteria have the most severe metabolic features and risk of cardiovascular disease. Hyperandrogenism in PCOS is closely related to the aggravation of abdominal obesity, and together with insulin resistance forms the metabolic core for the development of cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Igumnov et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: